STOCK PURCHASE AGREEMENT By and Between SPRINGWORKS THERAPEUTICS, INC. AND Glaxo Group Limited Dated as of September 6, 2022Stock Purchase Agreement • September 7th, 2022 • SpringWorks Therapeutics, Inc. • Biological products, (no disgnostic substances) • New York
THIS STOCK PURCHASE AGREEMENT (this “Agreement”), dated as of September 6, 2022, by and between Glaxo Group Limited (the “Purchaser”), a company existing under the laws of England with offices located at 980 Great West Road, Brentford, Middlesex, TW8 9GS, England, and SpringWorks Therapeutics, Inc. (the “Company”), a Delaware corporation, with its principal place of business at 100 Washington Blvd, Stamford, Connecticut, 06902.
